Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling
This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone...
Saved in:
Published in | Genetics in medicine Vol. 9; no. 8; pp. 487 - 495 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.08.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing.
A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure.
There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure.
These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings. |
---|---|
AbstractList | This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing.PURPOSEThis study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing.A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure.METHODSA total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure.There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure.RESULTSThere were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure.These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.CONCLUSIONSThese data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings. This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure. There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure. These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings. Purpose: This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. Methods: A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Date from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure. Results: There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure. Conclusions: These date suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings. |
Author | Jourkiv, Oxana Prindiville, Sheila A. Calzone, Kathleen A. Jenkins, Jean Kirsch, Ilan R. Dimond, Eileen Klein, Pam Soballe, Peter W. Liewehr, David J. Steinberg, Seth M. |
Author_xml | – sequence: 1 givenname: Jean surname: Jenkins fullname: Jenkins, Jean – sequence: 2 givenname: Kathleen A. surname: Calzone fullname: Calzone, Kathleen A. – sequence: 3 givenname: Eileen surname: Dimond fullname: Dimond, Eileen – sequence: 4 givenname: David J. surname: Liewehr fullname: Liewehr, David J. – sequence: 5 givenname: Seth M. surname: Steinberg fullname: Steinberg, Seth M. – sequence: 6 givenname: Oxana surname: Jourkiv fullname: Jourkiv, Oxana – sequence: 7 givenname: Pam surname: Klein fullname: Klein, Pam – sequence: 8 givenname: Peter W. surname: Soballe fullname: Soballe, Peter W. – sequence: 9 givenname: Sheila A. surname: Prindiville fullname: Prindiville, Sheila A. – sequence: 10 givenname: Ilan R. surname: Kirsch fullname: Kirsch, Ilan R. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17700386$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUctO3TAQtSqq8mj_oEJedRcYP67tsKNXvCQqJETXlq8zoUaJHeykUvl6fAVlwaJdzWjOw-M5-2QnpoiEfGVwxKDVxxdXP45gA0ygYIZxVJzDB7LHVgIaEErt1B5a0wgFsEv2S3kAYFpw-ER2mdYAwqg9Mt262KUxPGFHfRonl0NJkaaeTr_qe_Q35rIUGmIz1a4i32_Xp-yY0yljF8qUSphDHd9jxDl4OmOZacayDDOtuB9SWTJW6yUWHEK8_0w-9m4o-OW1HpCf52d368vm-ubian163Xhh-Nxw2UsvZdtyIY13humuZT1C26-QG2S46qRwG837duMkKuSt2f7IO62lrtgB-fbiO-X0uNSt7FjXwWFwEdNSrDJMyZVQ_yVyAMmqdSUevhKXzYidnXIYXf5j_x6zEk5eCD6nUjL21ofZbc8zZxcGy8Buk7M1Ofs-uSqW78Rv_v-SPQNJIJ2O |
CitedBy_id | crossref_primary_10_1007_s11606_018_4655_8 crossref_primary_10_1016_j_pec_2012_06_009 crossref_primary_10_1002_ajmg_c_30219 crossref_primary_10_1016_j_suc_2008_05_003 crossref_primary_10_3390_cancers10110424 crossref_primary_10_1016_j_jalz_2014_10_014 crossref_primary_10_1007_s10897_009_9238_8 crossref_primary_10_1007_s10897_011_9355_z crossref_primary_10_1111_j_1399_0004_2011_01813_x crossref_primary_10_1002_jgc4_1694 crossref_primary_10_1007_s10897_017_0082_y crossref_primary_10_1136_jmedgenet_2015_103740 crossref_primary_10_1111_j_1399_0004_2011_01811_x crossref_primary_10_1002_jgc4_1630 crossref_primary_10_1111_j_1524_4741_2009_00800_x crossref_primary_10_1007_s10897_011_9462_x crossref_primary_10_32725_kont_2021_035 crossref_primary_10_2196_resprot_3337 crossref_primary_10_1007_s10897_013_9655_6 crossref_primary_10_1007_s10897_015_9887_8 crossref_primary_10_1200_JCO_2013_51_3226 crossref_primary_10_1007_s10897_015_9848_2 crossref_primary_10_1007_s10689_012_9522_x crossref_primary_10_1002_ajmg_c_30308 crossref_primary_10_1111_ecc_13435 crossref_primary_10_1016_j_pec_2013_08_009 crossref_primary_10_1002_jgc4_1481 crossref_primary_10_1007_s10897_017_0073_z crossref_primary_10_1158_1055_9965_EPI_19_2_ASPO01 crossref_primary_10_1002_jgc4_1343 crossref_primary_10_1089_gte_2007_0525 crossref_primary_10_1002_jgc4_1441 crossref_primary_10_1007_s10689_016_9900_x crossref_primary_10_1007_s10689_009_9303_3 crossref_primary_10_1111_j_1399_0004_2010_01466_x crossref_primary_10_1089_gte_2006_0525 crossref_primary_10_1016_j_trci_2017_02_004 crossref_primary_10_1111_cge_13474 crossref_primary_10_1111_j_1399_0004_2010_01540_x crossref_primary_10_1002_jgc4_1627 crossref_primary_10_1007_s10897_012_9505_y crossref_primary_10_1188_13_CJON_397_404 crossref_primary_10_3389_fonc_2016_00120 crossref_primary_10_1159_000496556 crossref_primary_10_1016_j_trci_2019_09_013 crossref_primary_10_1093_jnci_djy015 crossref_primary_10_1007_s10689_010_9326_9 crossref_primary_10_1007_s10897_017_0183_7 |
Cites_doi | 10.1136/jmg.31.7.555 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 8FD FR3 P64 RC3 7X8 |
DOI | 10.1097/GIM.0b013e31812e6220 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1530-0366 |
EndPage | 495 |
ExternalDocumentID | 17700386 10_1097_GIM_0b013e31812e6220 |
Genre | Comparative Study Research Support, N.I.H., Intramural Randomized Controlled Trial Journal Article |
GrantInformation_xml | – fundername: Intramural NIH HHS |
GroupedDBID | --- .-D ..I .GJ 08G 39C 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 70F 7X7 88E 8FI 8FJ AAFWJ AAKAS AALRI AAXUO AAYEP AAYWO AAYXX ABAWZ ABJNI ABLJU ABUWG ACGFO ACGFS ACKTT ACRQY ACVFH ADBBV ADBIZ ADCNI ADVLN ADZCM AE3 AEJRE AENEX AEUPX AEXYK AFETI AFJKZ AFKRA AFPUW AFSHS AFTRI AGAYW AGCQF AHMBA AHSBF AHVBC AIGII AILAN AITUG AIZYK AJRNO AKBMS AKRWK AKYEP ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP AXYYD BENPR BKKNO BPHCQ BS7 BVXVI CCPQU CITATION CS3 DNIVK DU5 EBS EE. EIOEI EJD EX3 F5P FDB FDQFY FERAY FIZPM FSGXE FYUFA H0~ HMCUK JF9 JG8 JK3 JSO K-O KD2 M1P M41 N9A NQJWS N~M OAG OAH ODA OK1 OLG OVD OWU OWV OWW OWX OWY OWZ P-K P2P PHGZM PHGZT PQQKQ PROAC PSQYO R58 RNT RNTTT ROL S4R SNYQT SOHCF SOJ SRMVM SWTZT T8P TAOOD TBHMF TDRGL TEORI TSG UKHRP VVN W3M WOQ WOW XXN XYM YFH ZFV CGR CUY CVF ECM EFKBS EIF NPM PJZUB PPXIY 8FD FR3 P64 RC3 7X8 |
ID | FETCH-LOGICAL-c382t-24f4c44992348ca817d91fe09f5e28e1e5d43ab72f9ba4e6e2980386ca7747d43 |
ISSN | 1098-3600 1530-0366 |
IngestDate | Mon Jul 21 11:08:17 EDT 2025 Fri Jul 11 11:49:58 EDT 2025 Mon Jul 21 06:03:23 EDT 2025 Thu Apr 24 23:08:51 EDT 2025 Tue Jul 01 02:58:59 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c382t-24f4c44992348ca817d91fe09f5e28e1e5d43ab72f9ba4e6e2980386ca7747d43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 ObjectType-Undefined-3 |
OpenAccessLink | http://www.gimjournal.org/article/S1098360021038909/pdf |
PMID | 17700386 |
PQID | 20041038 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_68164536 proquest_miscellaneous_20041038 pubmed_primary_17700386 crossref_citationtrail_10_1097_GIM_0b013e31812e6220 crossref_primary_10_1097_GIM_0b013e31812e6220 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-08-01 |
PublicationDateYYYYMMDD | 2007-08-01 |
PublicationDate_xml | – month: 08 year: 2007 text: 2007-08-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Genetics in medicine |
PublicationTitleAlternate | Genet Med |
PublicationYear | 2007 |
References | Stone (10.1097/GIM.0b013e31812e6220_bb0155) Schwartz (10.1097/GIM.0b013e31812e6220_bb0100) Wooster (10.1097/GIM.0b013e31812e6220_bb0030) 10.1097/GIM.0b013e31812e6220_bb0055 10.1097/GIM.0b013e31812e6220_bb0110 Ormond (10.1097/GIM.0b013e31812e6220_bb0090) Biesecker (10.1097/GIM.0b013e31812e6220_bb0050) 10.1097/GIM.0b013e31812e6220_bb0115 Melzer (10.1097/GIM.0b013e31812e6220_bb0175) Zilberg (10.1097/GIM.0b013e31812e6220_bb0135) Dimond (10.1097/GIM.0b013e31812e6220_bb0035) 2003 Hughes (10.1097/GIM.0b013e31812e6220_bb0150) Miki (10.1097/GIM.0b013e31812e6220_bb0020) Claus (10.1097/GIM.0b013e31812e6220_bb0015) Calzone (10.1097/GIM.0b013e31812e6220_bb0045) Braithwaite (10.1097/GIM.0b013e31812e6220_bb0165) McBride (10.1097/GIM.0b013e31812e6220_bb0075) 10.1097/GIM.0b013e31812e6220_bb0010 Horowitz (10.1097/GIM.0b013e31812e6220_bb0130) Sangha (10.1097/GIM.0b013e31812e6220_bb0095) Lerman (10.1097/GIM.0b013e31812e6220_bb0140) 10.1097/GIM.0b013e31812e6220_bb0125 Helmes (10.1097/GIM.0b013e31812e6220_bb0080) Bluman (10.1097/GIM.0b013e31812e6220_bb0145) van Oostrom (10.1097/GIM.0b013e31812e6220_bb0040) Tavtigian (10.1097/GIM.0b013e31812e6220_bb0025) 10.1097/GIM.0b013e31812e6220_bb0060 Craig (10.1097/GIM.0b013e31812e6220_bb0170) Calzone (10.1097/GIM.0b013e31812e6220_bb0105) Wang (10.1097/GIM.0b013e31812e6220_bb0070) Coyne (10.1097/GIM.0b013e31812e6220_bb0160) 10.1097/GIM.0b013e31812e6220_bb0120 Thompson (10.1097/GIM.0b013e31812e6220_bb0065) Campbell (10.1097/GIM.0b013e31812e6220_bb0085) |
References_xml | – ident: 10.1097/GIM.0b013e31812e6220_bb0055 – ident: 10.1097/GIM.0b013e31812e6220_bb0060 doi: 10.1136/jmg.31.7.555 – ident: 10.1097/GIM.0b013e31812e6220_bb0070 – ident: 10.1097/GIM.0b013e31812e6220_bb0110 – ident: 10.1097/GIM.0b013e31812e6220_bb0015 – ident: 10.1097/GIM.0b013e31812e6220_bb0095 – ident: 10.1097/GIM.0b013e31812e6220_bb0120 – ident: 10.1097/GIM.0b013e31812e6220_bb0140 – ident: 10.1097/GIM.0b013e31812e6220_bb0050 – ident: 10.1097/GIM.0b013e31812e6220_bb0165 – ident: 10.1097/GIM.0b013e31812e6220_bb0020 – ident: 10.1097/GIM.0b013e31812e6220_bb0100 – ident: 10.1097/GIM.0b013e31812e6220_bb0150 – ident: 10.1097/GIM.0b013e31812e6220_bb0065 – ident: 10.1097/GIM.0b013e31812e6220_bb0155 – ident: 10.1097/GIM.0b013e31812e6220_bb0090 – ident: 10.1097/GIM.0b013e31812e6220_bb0045 – ident: 10.1097/GIM.0b013e31812e6220_bb0160 – ident: 10.1097/GIM.0b013e31812e6220_bb0175 – ident: 10.1097/GIM.0b013e31812e6220_bb0170 – ident: 10.1097/GIM.0b013e31812e6220_bb0115 – ident: 10.1097/GIM.0b013e31812e6220_bb0025 – ident: 10.1097/GIM.0b013e31812e6220_bb0080 – ident: 10.1097/GIM.0b013e31812e6220_bb0075 – ident: 10.1097/GIM.0b013e31812e6220_bb0085 – ident: 10.1097/GIM.0b013e31812e6220_bb0010 – ident: 10.1097/GIM.0b013e31812e6220_bb0130 – ident: 10.1097/GIM.0b013e31812e6220_bb0145 – ident: 10.1097/GIM.0b013e31812e6220_bb0125 – ident: 10.1097/GIM.0b013e31812e6220_bb0135 – ident: 10.1097/GIM.0b013e31812e6220_bb0105 – start-page: 225 year: 2003 ident: 10.1097/GIM.0b013e31812e6220_bb0035 article-title: Establishing a cancer genetics clinic – ident: 10.1097/GIM.0b013e31812e6220_bb0040 – ident: 10.1097/GIM.0b013e31812e6220_bb0030 |
SSID | ssj0017320 |
Score | 2.0868924 |
Snippet | This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing.
A... Purpose: This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic... This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 487 |
SubjectTerms | Adult Aged Anxiety - etiology Anxiety - psychology Apoptosis Regulatory Proteins BRCA1 Protein - genetics BRCA2 Protein - genetics Female Genetic Counseling Genetic Predisposition to Disease - psychology Humans Male Middle Aged Patient Satisfaction Telephone |
Title | Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17700386 https://www.proquest.com/docview/20041038 https://www.proquest.com/docview/68164536 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdKJxAvCMZX-fQDb1G6xHES57FUY6OjPFSb2FvlOI5WqTTVlmqifwp_LXexk7RlA8ZLVDmx6_Z-sc93v7sj5APmwOKeTl3MJYemG3jnRBq6MpaYbU4JpTF2ePw1Oj7jo_PwvNP5ucFaWpVpX61vjCv5H6lCG8gVo2TvINlmUGiAzyBfuIKE4fpPMp7IRVZ8n611Zrnktp6gg4Rz7SDjYoV8K3dZ6dXOx8lwUAVnYGqAbNYwtrCOMgYzOqB3lg4cwFfzEl03al6gAdFRTeD6pi57ZDpVhNpdF_1IY0kGGyvWAnAo5-vC2FBrGocz6DfKNODG2LkPZ3irbv8y09f64rKh4Duj_paxIm6ocvX6iulLg8jzNhfgZANnYmMx5XYrNvsyN8U4f1vyTSrho8_j1qbrMx0x5rVbXO3W39n5Gj5i7YmHUaa7o9wjewyOIKxL9gYnk28njY8qDpjJdWF_Uh2YmcQHN81mW_G55TRTaTWnj8kjexyhA4OtJ6SjF_vkvilQ-mOfPBhbuT4lyxZstAUbLXJagY0asNEGbLQC2wGj21CjFmoUoUYN1GgLNdpC7Rk5-3R4Ojx2bbkOVwWClS7jOVccTtAs4EJJ4cdZ4ufaS_JQM6F9HWY8kGnM8iSVXEeaJcILRKQkHEFiuPecdBcw4ZeEejxLoRuPFA85khUk2ieVFyiJpWJ0jwT1fzlVNpc9llSZT_8kyR5xm15Lk8vlL8-_r8U0hUUXPWlyoYvVFdZuxWmJ25-IhB_xMIh65IWRb_uNcYzu-OjVHWfzmjxs36g3pFtervRbUIjL9J1F5i9DKLNo |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Randomized+comparison+of+phone+versus+in-person+BRCA1%2F2+predisposition+genetic+test+result+disclosure+counseling&rft.jtitle=Genetics+in+medicine&rft.au=Jenkins%2C+Jean&rft.au=Calzone%2C+Kathleen+A.&rft.au=Dimond%2C+Eileen&rft.au=Liewehr%2C+David+J.&rft.date=2007-08-01&rft.issn=1098-3600&rft.volume=9&rft.issue=8&rft.spage=487&rft.epage=495&rft_id=info:doi/10.1097%2FGIM.0b013e31812e6220&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_GIM_0b013e31812e6220 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-3600&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-3600&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-3600&client=summon |